A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

NCT03283059 ·Status: UNKNOWN ·Phase: PHASE3

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

NCT01245530 ·Status: COMPLETED ·Phase: PHASE3

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

NCT02262975 ·Status: COMPLETED

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00104273 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

NCT00096473 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

NCT03363269 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

NCT02448784 ·Status: COMPLETED

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

NCT01089582 ·Status: COMPLETED

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

NCT02345213 ·Status: COMPLETED ·Phase: PHASE4

Non-Interventional Study With Aricept® Evess

NCT00889603 ·Status: COMPLETED

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

NCT05328115 ·Status: COMPLETED ·Phase: PHASE1

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

NCT00842816 ·Status: COMPLETED ·Phase: PHASE2

A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

NCT03197740 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

NCT00911807 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease

NCT02899091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease

NCT03112096 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Comparisons of Two Donepezil Formulations

NCT01297036 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of AR1005 in Patients with Lewy Body Disease

NCT06537076 ·Status: RECRUITING ·Phase: PHASE2

Monitoring Drug Efficacy in Patients with Alzheimer's Disease

NCT05801380 ·Status: RECRUITING

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT00744978 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

NCT00165763 ·Status: COMPLETED ·Phase: PHASE4

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00230568 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

NCT04592874 ·Status: COMPLETED ·Phase: PHASE2

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

NCT02955706 ·Status: COMPLETED ·Phase: PHASE4